Literature DB >> 3434597

Visceral involvement of dialysis amyloidosis.

J M Campistol1, A Cases, A Torras, M Soler, J Muñoz-Gómez, J Montoliu, J López-Pedret, L Revert.   

Abstract

Carpal tunnel syndrome, peripheral arthropathy, erosive spondyloarthropathy and lytic bone lesions have all been associated with dialysis amyloidosis. Recent studies indicate that beta 2-microglobulin is the major constituent protein in this new form of amyloidosis. Dialysis amyloidosis was reported to have a local rather than a systemic involvement, although its full extent is yet to be determined. We investigated 3 patients on maintenance hemodialysis with bilateral carpal tunnel syndrome and amyloid arthropathy and found amyloid depositions in several organs. These findings suggest that, in contrast to what had been thought previously, dialysis amyloidosis could have systemic as well as visceral distribution. The amyloid deposits found were resistant against potassium permanganate treatment and reacted with anti-human beta 2-microglobulin antibody.

Entities:  

Mesh:

Year:  1987        PMID: 3434597     DOI: 10.1159/000167505

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  10 in total

Review 1.  beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Beta 2 microglobulin haemodialysis related amyloidosis: distinctive gross features of gastrointestinal involvement.

Authors:  M Shimizu; T Manabe; T Matsumoto; Y Monobe; M Hirokawa; T Moriya; M Iida
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

3.  UPPER GASTROINTESTINAL MUCOSA IN CHRONIC RENAL FAILURE - AN ENDOSCOPIC AND HISTOLOGICAL EVALUATION.

Authors:  P P Varma; H S Pruthi; S K Thakur; P K Prasher; Balwinder Singh; J S Saini
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 4.  Beta-2 Microglobulin Amyloidosis: Past, Present, and Future.

Authors:  Ignacio Portales-Castillo; Jerry Yee; Hiroshi Tanaka; Andrew Z Fenves
Journal:  Kidney360       Date:  2020-10-21

5.  Pseudotumoral amyloidosis of beta 2-microglobulin origin in the buttock of a patient receiving long term haemodialysis.

Authors:  J Fernández-Alonso; C Rios-Camacho; A Valenzuela-Castaño; J L Rocha-Castilla
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

6.  Proteoglycans in haemodialysis-related amyloidosis.

Authors:  K Ohashi; M Hara; M Yanagishita; R Kawai; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  The gastrointestinal tract in uremia.

Authors:  J Y Kang
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

8.  Mixed systemic amyloidosis in a patient receiving long term haemodialysis.

Authors:  J Fernandez-Alonso; C Rios-Camacho; A Valenzuela-Castaño; W Hernanz-Mediano
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

9.  A case of pulmonary dialysis-related amyloidosis with reticular opacity of the lung in a patient undergoing long-term dialysis.

Authors:  Hidekazu Sugiura; Kayu Nakayama; Takashi Takei; Ken Tsuchiya; Kosaku Nitta
Journal:  NDT Plus       Date:  2010-11-24

10.  Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study.

Authors:  Eiichiro Kanda; Daniel Muenz; Brian Bieber; Aleix Cases; Francesco Locatelli; Friedrich K Port; Roberto Pecoits-Filho; Bruce M Robinson; Jeffrey Perl
Journal:  Clin Kidney J       Date:  2020-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.